BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 7814894)

  • 21. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.
    Ponomarev ED; Shriver LP; Maresz K; Dittel BN
    J Neurosci Res; 2005 Aug; 81(3):374-89. PubMed ID: 15959904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
    Oh SJ; Chung DH
    J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential cytokine and chemokine production characterizes experimental autoimmune meningitis and experimental autoimmune encephalomyelitis.
    Perrin PJ; Rumbley CA; Beswick RL; Lavi E; Phillips SM
    Clin Immunol; 2000 Feb; 94(2):114-24. PubMed ID: 10637096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-2 activated microglia engulf tumor infiltrating T cells in the central nervous system.
    Tamakawa N; Saio M; Suwa T; Ohe N; Yoshimura S; Iwama T; Shinoda J; Sakai N; Takami T
    Int J Mol Med; 2004 Apr; 13(4):497-503. PubMed ID: 15010848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis.
    Moransard M; Sawitzky M; Fontana A; Suter T
    Glia; 2010 Apr; 58(5):559-71. PubMed ID: 19941340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system.
    Toft-Hansen H; Babcock AA; Millward JM; Owens T
    J Neuroinflammation; 2007 Sep; 4():24. PubMed ID: 17883829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.
    Tan L; Gordon KB; Mueller JP; Matis LA; Miller SD
    J Immunol; 1998 May; 160(9):4271-9. PubMed ID: 9574529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global inhibition of IL-2 and IFN-gamma secreting T cells precedes recovery from acute monophasic experimental autoimmune encephalomyelitis.
    Jensen MA; Arnason BG; Toscas A; Noronha A
    J Autoimmun; 1996 Oct; 9(5):587-97. PubMed ID: 8933274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
    Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
    J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ; Petro TM
    Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Furlan R; Bergami A; Brambilla E; Butti E; De Simoni MG; Campagnoli M; Marconi P; Comi G; Martino G
    Gene Ther; 2007 Jan; 14(1):93-8. PubMed ID: 16929354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
    Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
    Selmaj K; Raine CS; Cross AH
    Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adhesion-related molecules in the central nervous system. Upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis.
    Cannella B; Cross AH; Raine CS
    Lab Invest; 1991 Jul; 65(1):23-31. PubMed ID: 1677055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective enrichment of Th1 CD45RBlow CD4+ T cells in autoimmune infiltrates in experimental allergic encephalomyelitis.
    Renno T; Zeine R; Girard JM; Gillani S; Dodelet V; Owens T
    Int Immunol; 1994 Mar; 6(3):347-54. PubMed ID: 7910482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.
    Karpus WJ; Lukacs NW; McRae BL; Strieter RM; Kunkel SL; Miller SD
    J Immunol; 1995 Nov; 155(10):5003-10. PubMed ID: 7594507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perforin and tumor necrosis factor alpha in the pathogenesis of experimental allergic encephalomyelitis: comparison of autoantigen induced and transferred disease in Lewis rats.
    Held W; Meyermann R; Qin Y; Mueller C
    J Autoimmun; 1993 Jun; 6(3):311-22. PubMed ID: 7691064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation in the central nervous system and Th17 responses are inhibited by IFN-gamma-Induced IL-18 binding protein.
    Millward JM; Løbner M; Wheeler RD; Owens T
    J Immunol; 2010 Aug; 185(4):2458-66. PubMed ID: 20644165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cxcl10 enhances blood cells migration in the sub-ventricular zone of mice affected by experimental autoimmune encephalomyelitis.
    Muzio L; Cavasinni F; Marinaro C; Bergamaschi A; Bergami A; Porcheri C; Cerri F; Dina G; Quattrini A; Comi G; Furlan R; Martino G
    Mol Cell Neurosci; 2010 Mar; 43(3):268-80. PubMed ID: 19969087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.